NCT04530409View on ClinicalTrials.gov

Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up

PHASE4UnknownINTERVENTIONAL
Enrollment

752

Participants

Timeline

Start Date

March 20, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

October 15, 2023

Conditions
Covid19Corticosteroids
Interventions
DRUG

Early-Corticosteroids

early use of dexamethasone/Methylprednisolone as early as laboratory evidence of high inflammatory markers

Trial Locations (1)

11433

Asalam, Maadi

Sponsors

Lead Sponsor

ClinAmygate
All Listed Sponsors
lead

ClinAmygate

OTHER

NCT04530409 - Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up | Biotech Hunter | Biotech Hunter